Jemma Arakelyan: Barriers to Access to Cancer Care for Patients from the Conflict-affected Region
Jemma Arakelyan shared on X:
“Check out our latest study, ‘Barriers to Access to Cancer Care for Patients from the Conflict-affected Region of the Nagorno-Karabakh Republic: A Qualitative Study,’ in PLOS Global Public Health.”
Source: Jemma Arakelyan/X
Dr. Jemma Arakelyan is a medical oncologist and Ph.D. candidate at the City University of Hong Kong. Her research focuses on developing new anticancer treatments and understanding the underlying mechanisms of cancer progression.In addition to her academic pursuits, she is an active member of several scientific organizations, including the European School of Oncology (ESO), where she served as an ambassador in Armenia from 2020-2022. Dr. Arakelyan is also the president of the Institute of Cancer and Crisis. The Institute is dedicated to promoting áwareness and support for cancer patients facing critical situations like war, pandemic, etc.